353 related articles for article (PubMed ID: 30129270)
21. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
23. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
[TBL] [Abstract][Full Text] [Related]
25. Expression of Oxytocin Receptors in Canine Mammary Tumours.
Benavente MA; Bianchi CP; Aba MA
J Comp Pathol; 2019 Jul; 170():26-33. PubMed ID: 31375156
[TBL] [Abstract][Full Text] [Related]
26. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.
Queiroga FL; Perez-Alenza MD; González-Gil A; Silván G; Peña L; Illera JC
Vet Comp Oncol; 2017 Jun; 15(2):383-390. PubMed ID: 26463704
[TBL] [Abstract][Full Text] [Related]
27. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
29. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
31. Expression of autophagy-related protein Beclin-1 in malignant canine mammary tumors.
Liu JL; Chang KC; Lo CC; Chu PY; Liu CH
BMC Vet Res; 2013 Apr; 9():75. PubMed ID: 23578251
[TBL] [Abstract][Full Text] [Related]
32. Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time.
Diessler ME; Castellano MC; Portiansky EL; Burns S; Idiart JR
Vet Comp Oncol; 2017 Jun; 15(2):450-461. PubMed ID: 26833549
[TBL] [Abstract][Full Text] [Related]
33. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
Pereira PD; Lopes CC; Matos AJ; Cortez PP; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2010; 143(2-3):87-93. PubMed ID: 20153868
[TBL] [Abstract][Full Text] [Related]
34. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
35. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ
Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401
[TBL] [Abstract][Full Text] [Related]
38. Tumour-associated macrophages: Relation with progression and invasiveness, and assessment of M1/M2 macrophages in canine mammary tumours.
Monteiro LN; Rodrigues MA; Gomes DA; Salgado BS; Cassali GD
Vet J; 2018 Apr; 234():119-125. PubMed ID: 29680383
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of IGF-I and IGF-II expression in canine mammary tumours: Prognostic and diagnostic role.
Ozmen O
Acta Vet Hung; 2020 Sep; 68(3):269-274. PubMed ID: 33221734
[TBL] [Abstract][Full Text] [Related]
40. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
